American Journal of Ophthalmology
Volume 135, Issue 1 , Pages 20-25 , January 2003

Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant

  • Irene C Kuo, MD

      Affiliations

    • Francis I. Proctor Foundation and the Department of Ophthalmology (I.C.K., Y.I., C.S., T.P.M.), University of California San Francisco, San Francisco, California, USA
    • ,
  • Yumi Imai, DVM, PhD

      Affiliations

    • Francis I. Proctor Foundation and the Department of Ophthalmology (I.C.K., Y.I., C.S., T.P.M.), University of California San Francisco, San Francisco, California, USA
    • ,
  • Carol Shum, BS

      Affiliations

    • Francis I. Proctor Foundation and the Department of Ophthalmology (I.C.K., Y.I., C.S., T.P.M.), University of California San Francisco, San Francisco, California, USA
    • ,
  • Daniel F Martin, MD

      Affiliations

    • Department of Ophthalmology (D.F.M.), Emory University School of Medicine, Atlanta, Georgia, USA
    • ,
  • Baruch D Kuppermann, MD, PhD

      Affiliations

    • Department of Ophthalmology (B.D.K.), University of California Irvine, Irvine, California, USA
    • ,
  • Todd P Margolis, MD, PhD

      Affiliations

    • Corresponding Author InformationInquiries to Todd P. Margolis, MD, PhD, F. I. Proctor Foundation, 95 Kirkham, UCSF, San Francisco, CA 94143-0944, USA; fax: (415) 476-0527
    • Francis I. Proctor Foundation and the Department of Ophthalmology (I.C.K., Y.I., C.S., T.P.M.), University of California San Francisco, San Francisco, California, USA

,Accepted 1 May 2002.

References 

  1. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223–1227
  2. Cunningham ET, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339:236–244
  3. Liu W, Kuppermann BD, Martin DF, Wolitz RA, Margolis TP. Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis. J Infect Dis. 1998;177:1176–1181
  4. Jabs DA, Enger C, Dunn JP, Forman M. Cytomegalovirus retinitis and resistance (ganciclovir resistance. CMV retinitis and viral resistance group). J Infect Dis. 1998;177:770–773
  5. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992;358:162–164
  6. Littler E, Stuart AD, Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature. 1992;358:160–162
  7. Lurain NS, Spafford LE, Thompson KD. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol. 1994;68:4427–4431
  8. Chou S, Erice A, Jordan MC, et al.  Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis. 1995;171:576–583
  9. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis. 1995;172:239–242
  10. Boivin G, Chou S, Quirk MR, Erice A, Jordan MC. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis. 1996;173:523–528
  11. Baldanti F, Underwood MR, Stanat SC, et al.  Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol. 1996;70:1390–1395
  12. Lurain NS, Thompson KD, Holmes EW, et al.  Point mutation in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol. 1992;66:7146–7152
  13. Sullivan V, Biron KK, Talarico C, et al.  A point mutation in the cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphoylmethoxyalkyl derivatives. Antimicrob Agents Chemother. 1993;37:3719–3725
  14. Collier AC, Chandler SH, Handsfield HH, Corey L, McDougall JK. Identification of multiple strains of cytomegalovirus in homosexual men. J Infect Dis. 1989;159:123–126
  15. Chern KC, Changler DB, Martin DF, Kuppermann BD, Wolitz RA, Margolis TP. Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis. 1998;178:1149–1153
  16. Kuppermann BD, Quiceno JI, Flores-Aguilar M, et al.  Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis; implications for therapy. J Infect Dis. 1993;168:1506–1509
  17. Erice A, Chour S, Biron KK, et al.  Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med. 1989;320:289–293
  18. Piketty C, Bardin B, Gilquin J, et al.  Low plasma concentrations achieved with conventional schedules of administration of ganciclovir in patients with AIDS. J Infect Dis. 1996;174:188–190
  19. Martin DF, Parks DG, Mellow SD. Treatment of CMV retinitis with an intraocular sustained-release ganciclovir implant. A randomized trial. Arch Ophthalmol. 1994;112:1531–1539
  20. Drew WL, Miner R, Saleh E. Antiviral susceptibility testing of cytomegalovirus (criteria for detecting resistance to antivirals). Clin Diagn Virol. 1993;1:179–185
  21. Martin DF, Dunn JP, Davis JL, et al.  Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy (Recommendations of the International AIDS Society-USA Panel). Am J Ophthalmol. 1999;127:329–339
  22. Roth DB, Feuer WJ, Blenke AJ, Davis JL. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant. Am J Ophthalmol. 1999;127:276–282
  23. Marx JL, Kaputsa MA, Patel SS, et al.  Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:815–820
  24. Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegaloirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 1995;119:587–596
  25. Jacobson MA, Wulfsohn M, Feinberg JE, et al.  Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093). AIDS. 1994;8:451–459
  26. Cormack B. Directed mutagenesis using the polymerase chain reaction. In:  Ausubel FM,  Brent R,  Kingston RE editor. Current protocols in molecular biology. Volume 1:New York: John Wiley & Sons; 1997; 8:5.1–8.5.10
  27. Smith IL, Cherington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis. 1997;176:69–77
  28. Chou SW, Lurain NS, Weinberg A, et al.  Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob Agents Chemother. 1999;43:1500–1502
  29. Liu W, Shum CC, Kuppermann BD, Martin DM, Hall A, Margolis TP. Prevalence of CMV UL97 resistance mutations in untreated patients with CMV retinitis. J Infect Dis. 2000;182:1234–1238
  30. Plotkin SA, Drew WL, Felsenstein D, Hirsch MS. Sensitivities of clinical isolates of human cytomegolovirus to 9-(1,3-dihydroxy-2-propoxymethyl) guanine. J Infect Dis. 1985;152:833–834
  31. Jabs DA, Wingard JR, De Bustros S, De Miranda P, Saral R, Santos GW. BW B759U for cytomegalovirus retinitis (intraocular drug penetration). Arch Ophthalmol. 1986;104:1436–1437
  32. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL, Biron K. Ganciclovir-resistant cytomegalovirus clinical isolates (mode of resistance to ganciclovir). Antimicrob Agents Chemother. 1991;35:2191–2197
  33. Drew WL. Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance. J Acquir Immune Defic Syndr. 1991;4:S42–S46
  34. McCann JD, Margolis TP, Wong MG, et al.  A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis. Am J Ophthalmol. 1995;120:219–226

☆ This study was supported in part by Research to Prevent Blindness, Inc., New York, New York; Fight for Sight, New York, New York; and the Ralph and Sophie Heintz Lab and Lecture Fund (T.P.M.). Drs. Kuppermann and Martin have served as consultants to Bausch & Lomb/Chiron Vision.

☆☆ InternetAdvance publication at ajo.com Nov 7, 2002.

PII: S0002-9394(02)01758-0

American Journal of Ophthalmology
Volume 135, Issue 1 , Pages 20-25 , January 2003

Article Tools